Announcing the Mussallem Congenital Heart Defects Alliance Innovation Fellowship
Impact1 and the Mussallem CHD Alliance are launching a new full-time, in-person fellowship that is built on Stanford Biodesign’s decades-long expertise in health tech innovation. In this 10-month fellowship, you will apply the rigorous Biodesign process that you learned in a prior Stanford Biodesign program or course within the clinical area of congenital heart defects.
Eligibility requirements:
- Candidates must have been trained on Stanford Campus by Stanford Biodesign Faculty.
- You will be required to provide proof of eligibility to work in the US; Stanford Biodesign may be able to sponsor a student or researcher visa.
- Only complete applications that were submitted by the deadline will be considered.
Timeline:
Applications are due March 1, 2026 at 11:59pm PT.
Invitations to interview will be sent by March 10, 2026.
30-minute virtual interviews will take place on March 18, 19 or 20 with one or more members of the fellowship faculty team.
Acceptance decisions will be sent by April 2, 2026.
The fellowship will start on August 3, 2026.
Warmly,
Antje
---------
Antje Kirschner
akirsch@stanford.edu
Chief of Staff, Impact1